Biomea Fusion, Inc. Diluted Shares Outstanding (Weighted Average)
Biomea Fusion, Inc. (BMEA) reported Diluted Shares Outstanding (Weighted Average) of 72.36 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 72.36M shares, a 78.09% increase year-over-year.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 72.30M shares, a 97.39% increase year-over-year.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 71.55M shares, a 97.30% increase year-over-year.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 59.85M shares, a 65.23% increase year-over-year.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 52.23M shares, a 44.65% increase from fiscal 2024.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 36.11M shares, a 5.86% increase from fiscal 2023.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 34.11M shares, a 16.52% increase from fiscal 2022.
- Biomea Fusion, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 29.27M shares, a 22.69% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 72.36M shares 10-Q · filed 2026-08-05 | 72.33M shares 10-Q · filed 2026-08-05 | 72.07M shares derived: average of 3 quarters · filed 2026-08-05 | 69.01M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 72.30M shares 10-Q · filed 2026-05-11 | 71.93M shares derived: average of 2 quarters · filed 2026-05-11 | 67.90M shares derived: average of 3 quarters · filed 2026-05-11 | 61.08M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 71.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 65.70M shares derived: average of 2 quarters · filed 2026-03-24 | 57.34M shares derived: average of 3 quarters · filed 2026-08-05 | 52.23M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 59.85M shares 10-Q · filed 2025-11-04 | 50.24M shares derived: average of 2 quarters · filed 2026-08-05 | 45.79M shares 10-Q · filed 2025-11-04 | 43.34M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 40.63M shares 10-Q · filed 2026-08-05 | 38.64M shares 10-Q · filed 2026-08-05 | 37.84M shares derived: average of 3 quarters · filed 2026-08-05 | 37.44M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 36.63M shares 10-Q · filed 2026-05-11 | 36.45M shares derived: average of 2 quarters · filed 2026-05-11 | 36.37M shares derived: average of 3 quarters · filed 2026-05-11 | 36.29M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 36.27M shares 10-K · filed 2025-03-31 | 36.24M shares derived: average of 2 quarters · filed 2025-11-04 | 36.18M shares derived: average of 3 quarters · filed 2025-11-04 | 36.11M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 36.22M shares 10-Q · filed 2025-11-04 | 36.13M shares derived: average of 2 quarters · filed 2025-11-04 | 36.05M shares 10-Q · filed 2025-11-04 | 35.98M shares derived: average of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | 36.04M shares 10-Q · filed 2025-08-05 | 35.97M shares 10-Q · filed 2025-08-05 | 35.90M shares derived: average of 3 quarters · filed 2025-08-05 | 35.84M shares derived: average of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | 35.89M shares 10-Q · filed 2025-05-05 | 35.82M shares derived: average of 2 quarters · filed 2025-05-05 | 35.77M shares derived: average of 3 quarters · filed 2025-05-05 | 35.66M shares derived: average of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | 35.75M shares 10-K · filed 2025-03-31 | 35.70M shares derived: average of 2 quarters · filed 2025-03-31 | 35.59M shares derived: average of 3 quarters · filed 2025-03-31 | 34.11M shares 10-K · filed 2026-03-24 |
| 2023-09-30 | 35.65M shares 10-K · filed 2025-03-31 | 35.50M shares derived: average of 2 quarters · filed 2025-03-31 | 33.55M shares 10-Q · filed 2024-10-29 | 32.51M shares derived: average of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | 35.35M shares 10-K · filed 2025-03-31 | 32.48M shares 10-Q · filed 2024-07-31 | 31.46M shares derived: average of 3 quarters · filed 2025-03-31 | 30.92M shares derived: average of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | 29.59M shares 10-K · filed 2025-03-31 | 29.51M shares derived: average of 2 quarters · filed 2025-03-31 | 29.45M shares derived: average of 3 quarters · filed 2025-03-31 | 29.39M shares derived: average of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | 29.44M shares 10-K · filed 2024-03-28 | 29.38M shares derived: average of 2 quarters · filed 2024-03-28 | 29.32M shares derived: average of 3 quarters · filed 2024-03-28 | 29.27M shares 10-K · filed 2025-03-31 |
| 2022-09-30 | 29.32M shares 10-K · filed 2024-03-28 | 29.26M shares derived: average of 2 quarters · filed 2024-03-28 | 29.21M shares 10-Q · filed 2023-10-30 | 29.18M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | 29.20M shares 10-K · filed 2024-03-28 | 29.16M shares 10-Q · filed 2023-07-31 | 29.13M shares derived: average of 3 quarters · filed 2024-03-28 | 29.10M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | 29.13M shares 10-K · filed 2024-03-28 | 29.09M shares derived: average of 2 quarters · filed 2024-03-28 | 29.06M shares derived: average of 3 quarters · filed 2024-03-28 | 28.09M shares derived: average of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | 29.06M shares 10-K · filed 2023-03-28 | 29.03M shares derived: average of 2 quarters · filed 2023-03-28 | 27.74M shares derived: average of 3 quarters · filed 2023-03-28 | 23.86M shares 10-K · filed 2024-03-28 |
| 2021-09-30 | 29.00M shares 10-K · filed 2023-03-28 | 27.08M shares derived: average of 2 quarters · filed 2023-03-28 | 22.11M shares 10-Q · filed 2022-11-07 | |
| 2021-06-30 | 25.16M shares 10-K · filed 2023-03-28 | 18.56M shares derived: average of 2 quarters · filed 2023-03-28 | ||
| 2021-03-31 | 11.96M shares 10-K · filed 2023-03-28 | |||
| 2020-12-31 | 10.53M shares 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |